Myriad Genetics
MYGN
#7328
Rank
C$0.78 B
Marketcap
C$8.18
Share price
-7.87%
Change (1 day)
-28.64%
Change (1 year)

Earnings for Myriad Genetics (MYGN)

Earnings in 2026 (TTM): -C$0.53 Billion

According to Myriad Genetics's latest financial reports the company's current earnings are C$0.82 Billion. In 2025 the company made an earning of -C$0.54 Billion a decrease over its 2024 earnings that were of -C$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Myriad Genetics from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.53 Billion-2.04%
2025 -C$0.54 Billion218.91%
2024 -C$0.17 Billion-53.49%
2023 -C$0.37 Billion88.72%
2022 -C$0.2 Billion172.08%
2021 -C$70.62 Million
2019 -C$36.78 Million-175.14%
2018 C$48.94 M-70.81%
2017 C$0.16 B22.22%
2016 C$0.13 B-38.8%
2015 C$0.22 B-6.12%
2014 C$0.23 B-41.07%
2013 C$0.40 B46.67%
2012 C$0.27 B15.84%
2011 C$0.23 B17.6%
2010 C$0.20 B-15.96%
2009 C$0.24 B
2007 -C$58.28 Million40.96%
2006 -C$41.35 Million
2003 -C$48.01 Million34.8%
2002 -C$35.62 Million89.21%
2001 -C$18.83 Million3.93%
2000 -C$18.12 Million21.76%
1999 -C$14.88 Million-25.61%
1998 -C$20 Million38.83%
1997 -C$14.41 Million-24.26%
1996 -C$19.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
C$11.37 B-2,208.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-C$0.26 Billion-52.79%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.20 B-138.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-C$48.9 Million-90.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
C$0.48 B-190.78%๐Ÿ‡บ๐Ÿ‡ธ USA